These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37566734)

  • 1. Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the
    D'Erasmo MP; Akins NS; Ma P; Jing Y; Swanger SA; Sharma SK; Bartsch PW; Menaldino DS; Arcoria PJ; Bui TT; Pons-Bennaceur A; Le P; Allen JP; Ullman EZ; Nocilla KA; Zhang J; Perszyk RE; Kim S; Acker TM; Taz A; Burton SL; Coe K; Fritzemeier RG; Burnashev N; Yuan H; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2023 Sep; 14(17):3059-3076. PubMed ID: 37566734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
    Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships and pharmacophore model of a noncompetitive pyrazoline containing class of GluN2C/GluN2D selective antagonists.
    Acker TM; Khatri A; Vance KM; Slabber C; Bacsa J; Snyder JP; Traynelis SF; Liotta DC
    J Med Chem; 2013 Aug; 56(16):6434-56. PubMed ID: 23909910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs.
    Chou TH; Kang H; Simorowski N; Traynelis SF; Furukawa H
    Mol Cell; 2022 Dec; 82(23):4548-4563.e4. PubMed ID: 36309015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792.
    Sapkota K; Burnell ES; Irvine MW; Fang G; Gawande DY; Dravid SM; Jane DE; Monaghan DT
    Neuropharmacology; 2021 Dec; 201():108818. PubMed ID: 34610288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
    Acker TM; Yuan H; Hansen KB; Vance KM; Ogden KK; Jensen HS; Burger PB; Mullasseril P; Snyder JP; Liotta DC; Traynelis SF
    Mol Pharmacol; 2011 Nov; 80(5):782-95. PubMed ID: 21807990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
    Nouhi M; Zhang X; Yao N; Chergui K
    CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
    Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
    Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of subtype-selective competitive antagonism for GluN2C/2D-containing NMDA receptors.
    Wang JX; Irvine MW; Burnell ES; Sapkota K; Thatcher RJ; Li M; Simorowski N; Volianskis A; Collingridge GL; Monaghan DT; Jane DE; Furukawa H
    Nat Commun; 2020 Jan; 11(1):423. PubMed ID: 31969570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.
    Chen QY; Li XH; Lu JS; Liu Y; Lee JA; Chen YX; Shi W; Fan K; Zhuo M
    Mol Brain; 2021 Mar; 14(1):60. PubMed ID: 33766086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.
    Alsaad HA; DeKorver NW; Mao Z; Dravid SM; Arikkath J; Monaghan DT
    Neurochem Res; 2019 Jan; 44(1):61-77. PubMed ID: 29651654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.
    Perszyk RE; DiRaddo JO; Strong KL; Low CM; Ogden KK; Khatri A; Vargish GA; Pelkey KA; Tricoire L; Liotta DC; Smith Y; McBain CJ; Traynelis SF
    Mol Pharmacol; 2016 Dec; 90(6):689-702. PubMed ID: 27625038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C N-methyl-D-aspartate receptors.
    Pineau L; Buhler E; Tarhini S; Bauer S; Crepel V; Watrin F; Cardoso C; Represa A; Szepetowski P; Burnashev N
    Epilepsia; 2024 Jul; 65(7):2111-2126. PubMed ID: 38717560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin.
    Bettini E; De Martin S; Mattarei A; Pappagallo M; Stahl SM; Bifari F; Inturrisi CE; Folli F; Traversa S; Manfredi PL
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA Receptors Containing GluN2B/2C/2D Subunits Mediate an Increase in Glutamate Release at Hippocampal CA3-CA1 Synapses.
    Prius-Mengual J; Pérez-Rodríguez M; Andrade-Talavera Y; Rodríguez-Moreno A
    Mol Neurobiol; 2019 Mar; 56(3):1694-1706. PubMed ID: 29916144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of AICP as a GluN2C-Selective
    Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A
    Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.